Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human APH1A ELISA Kit (AC3340)
Cat.#: ASET-1929
Specifications
Description Human APH1A ELISA Kit allows for the in vitro quantitative determination of human APH1A concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.938 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.563-100 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1691 Human Aldolase C ELISA Kit (AC3102) Quantitative inquiry ASET-2384 Mouse LECT2 ELISA Kit (AC3795) Quantitative inquiry ASET-2360 Human Stomatin ELISA Kit (AC3771) Quantitative inquiry ASET-1971 Canine Adiponectin ELISA Kit (AC3382) Quantitative inquiry ASET-1192 Human DISC1 ELISA Kit (AC2603) Quantitative inquiry ASET-2224 Human Apelin ELISA Kit (AC3635) Quantitative inquiry ASET-1734 Mouse GDF11 ELISA Kit (AC3145) Quantitative inquiry ASET-1721 Rat Mitofusin 1 ELISA Kit (AC3132) Quantitative inquiry ASET-1744 Human Oligodendrocyte Specific Protein ELISA Kit (AC3155) Quantitative inquiry ASET-1100 Human IL-6 ELISA Kit (AC2511) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket